Reported Standalone quarterly numbers for Softrak Biotech are:
Net Sales at Rs 0.02 crore in September 2023 up 1226.67% from Rs. 0.00 crore in September 2022.
Story continues below Advertisement
Quarterly Net Profit at Rs. 0.00 crore in September 2023 down 59.09% from Rs. 0.00 crore in September 2022.
EBITDA stands at Rs. 0.00 crore in September 2023 down 0% from Rs. 0.00 crore in September 2022.
Softrak Biotech shares closed at 5.93 on December 21, 2023 (BSE) and has given 0.85% returns over the last 6 months and 459.43% over the last 12 months.
Story continues below Advertisement
| Softrak Biotech | | Standalone Quarterly Results | in Rs. Cr. |
|
| Sep'23 | Jun'23 | Sep'22 | | Net Sales/Income from operations | 0.02 | 0.03 | 0.00 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 0.02 | 0.03 | 0.00 | | EXPENDITURE | | Consumption of Raw Materials | -- | -- | -- | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -- | -- | -- | | Power & Fuel | -- | -- | -- | | Employees Cost | 0.02 | 0.01 | 0.02 | | Depreciation | -- | -- | -- | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 0.00 | 0.02 | 0.01 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 0.00 | 0.01 | -0.02 | | Other Income | 0.00 | -- | 0.03 | | P/L Before Int., Excpt. Items & Tax | 0.00 | 0.01 | 0.00 | | Interest | -- | -- | -- | | P/L Before Exceptional Items & Tax | 0.00 | 0.01 | 0.00 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 0.00 | 0.01 | 0.00 | | Tax | 0.00 | 0.00 | 0.00 | | P/L After Tax from Ordinary Activities | 0.00 | 0.01 | 0.00 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 0.00 | 0.01 | 0.00 | | Equity Share Capital | 45.08 | 45.08 | 45.08 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -- | 0.00 | -- | | Diluted EPS | -- | -- | -- | | EPS After Extra Ordinary | | Basic EPS | -- | 0.00 | -- | | Diluted EPS | -- | -- | -- | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
